Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04610528
Title A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression (TOT-HER3)
Acronym TOT-HER3
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
ICO Badalona Badalona Barcelona Spain Details
Institut Català d'Oncologia Hospitalet Hospitalet de Llobregat Barcelona Spain Details
Hospital Universitario de Canarias Tenerife Islas Canarias 38320 Spain Details
Hospital Universitario de Fuenlabrada Fuenlabrada Madrid Spain Details
Hospital Universitari Vall d'Hebrón Barcelona 08035 Spain Details
Hospital Clínic de Barcelona Barcelona 08036 Spain Details
Centro Integral Oncológico Clara Campal (CIOCC) Madrid Spain Details
Hospital Universitario 12 de Octubre Madrid Spain Details
Hospital Universitario Virgen del Rocio Sevilla Spain Details
Hospital Clinico Universitario de Valencia Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field